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Abstract Influenza virus has a high mutation rate, such that within one host different viral
variants can emerge. Evidence suggests that influenza virus variants are more prevalent in pregnant
and/or obese individuals due to their impaired interferon response. We have recently shown that
the non-allergic, paucigranulocytic subtype of asthma is associated with impaired type I interferon
production. Here, we seek to address if this is associated with an increased emergence of influenza
virus variants. Compared to controls, mice with paucigranulocytic asthma had increased disease
severity and an increased emergence of influenza virus variants. Specifically, PB1 mutations
exclusively detected in asthmatic mice were associated with increased polymerase activity.
Furthermore, asthmatic host-derived virus led to increased disease severity in wild-type mice.
Taken together, these data suggest that at least a subset of patients with asthma may be more
susceptible to severe influenza and may be a possible source of new influenza virus variants.
Introduction
Similar to many other RNA viruses, the influenza virus RNA polymerase has poor proofreading activ-
ity, resulting in a high rate of viral mutations (Van den Hoecke et al., 2015). Accordingly, even if an
influenza virus infection occurs with a defined molecular clone, there will be rapid generation of viral
variants that possess one or more mutations relative to the original virus strain. Many viral mutants
are of reduced or unaltered virulence compared to the wild-type (WT) parental viral strain (Van den
Hoecke et al., 2015). However, viral variants that display increased virulence can also emerge.
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Modelling studies suggest that there are a higher number of influenza virus variants in individuals
that suffer from severe disease (Reperant et al., 2014). This may reflect the fact that mutations that
are of increased virulence but of reduced fitness are able to replicate in immunocompromised indi-
viduals and not in individuals that have a fully competent immune response. Alternatively, in individ-
uals with severe disease there may be additional rounds of virus replication, which represent
additional opportunities for viral mutagenesis (Reperant et al., 2014). Consistent with these obser-
vations, pregnant mice infected with influenza virus have an increased rate of viral mutations com-
pared to their non-pregnant counterparts (Engels et al., 2017). Similarly, the impaired interferon
response of obese mice is thought to drive the emergence of virulent influenza virus variants
(Honce et al., 2020). These data raise the question whether asthma, a host co-morbidity frequently
associated with an impaired interferon response (Wark et al., 2005; Contoli et al., 2006), also facili-
tates the emergence of influenza virus variants.
The impact of pre-existing asthma on the severity of influenza virus infection is controversial. Dur-
ing the 2009 H1N1 pandemic asthma was identified as the single most common underlying medical
condition in individuals hospitalised with influenza (Nguyen-Van-Tam et al., 2010; Morris et al.,
2012). Individuals with asthma are known to have a greater risk of (i) admission to the hospital
(Neuzil et al., 2000; O’Riordan et al., 2010; Van Kerkhove et al., 2011; Miller et al., 2008), (ii)
being treated in the intensive care unit (Bueving et al., 2004; Libster et al., 2010), (iii) requiring a
greater number of outpatient visits (Morris et al., 2012; Neuzil et al., 2000; Miller et al., 2008),
and (iv) developing pneumonia (O’Riordan et al., 2010; Dawood et al., 2011) upon influenza virus
infection. Whilst some of these observations may be attributable to the fact that influenza virus can
exacerbate the symptoms of asthma (Obuchi et al., 2013), Dawood and colleagues demonstrated
that the majority of patients with asthma were hospitalised for influenza in the absence of an acute
asthma attack (Dawood et al., 2011). However, a global analysis of pH1N1 cases suggests that
once hospitalised, influenza patients with asthma have a greater survival rate than patients with other
conditions (Van Kerkhove et al., 2011). Consistent with these findings, studies using a mouse
model of disease actually suggest that mice with the cardinal features of asthma display reduced dis-
ease severity following infection with influenza virus (Furuya et al., 2015; Samarasinghe et al.,
2014; Ishikawa et al., 2012).
The controversies in the literature regarding the interactions between asthma and influenza
appear hard to reconcile. However, it is important to recognise that asthma is a heterogenous dis-
ease, consisting of many different phenotypes (Svenningsen and Nair, 2017). It is possible that dif-
ferent subtypes of asthma display differing degrees of synergism with influenza virus. For example,
the aforementioned mouse studies used either ovalbumin (OVA), fungal allergens, or house dust
mite for sensitisation (Furuya et al., 2015; Samarasinghe et al., 2014; Ishikawa et al., 2012), all of
which induce an eosinophilic asthma which was characterised by high levels of IgE and eosinophilia.
Whilst approximately 40% of adults suffer from this allergic ‘eosinophilic asthma’, a large percentage
of asthma patients suffer from non-allergic asthma (i.e. where asthma is observed in the absence of
eosinophilic asthma). One such subtype is paucigranulocytic asthma in which airway remodelling
occurs in the absence of eosinophilia or neutrophilia.
Here, we sought to determine the role of paucigranulocytic asthma, using an established experi-
mental mouse model (Arikkatt et al., 2017), in the generation of influenza virus variants. We chose
to focus on paucigranulocytic asthma for this study as (i) the relationship between this specific phe-
notype of non-allergic asthma and severe influenza has yet to be studied, (ii) in some populations
paucigranulocytic asthma can affect up to 40% of asthmatic patients (Schleich et al., 2013), and (iii)
paucigranulocytic asthma is associated with an impaired interferon response (Arikkatt et al., 2017).
We show that mice with a paucigranulocytic asthma phenotype (henceforth referred to as ‘asthmatic
mice’) have increased intra-host influenza viral diversity compared to control mice. Importantly, two
of the viral mutations that emerged in asthmatic mice were associated with increased viral replication
and polymerase activity. Together, these data provide strong evidence that host–viral interactions
are bidirectional and that host co-morbidities can influence the evolution of influenza virus.
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Results
Pneumonia virus of mice (PVM)-infection of RAGE-deficient mice
induces the cardinal features of paucigranulocytic asthma
To investigate the effect of asthma on the severity of influenza we employed a previously established
model of paucigranulocytic asthma (Arikkatt et al., 2017). In this model, an early-life PVM infection
followed by reinfection with PVM later in life in mice deficient in the receptor for advanced glycation
endproducts (RAGE), encoded by the Ager gene, promotes airway remodelling characteristic of
asthma (Arikkatt et al., 2017). To confirm this phenotype, the number of mucus-secreting cells and
airway smooth muscle mass (ASM) was assessed in PVM-infected RAGE-deficient mice and mock-
infected RAGE-deficient mice. Importantly, RAGE-deficient mice that received only an early life PVM
infection were not included in these experiments as we have previously shown that an early life PVM
infection, followed by a later life infection with influenza A virus (IAV), also results in an asthma-like
phenotype (Arikkatt et al., 2017). Consistent with our previous findings (Arikkatt et al., 2017), an
early and later life PVM infection in RAGE-deficient mice resulted in a significant increase in the num-
ber of mucus secreting cells and ASM mass (Figure 1A). To confirm that the observed structural
changes were not associated with a marked pro-inflammatory phenotype or strong interferon
response, various cytokines were assessed in the lungs of asthmatic and non-asthmatic mice. Consis-
tent with our previous findings (Arikkatt et al., 2017) asthmatic mice had significantly lower pulmo-





































































































































































































































































Figure 1. Pneumonia virus of mice (PVM)-infection (at 7 days of age and reinfection at 35 days of age) of RAGE-deficient mice induces the cardinal
features of asthma. (A) (Left) Percentage of airway epithelial cells (AECs) producing mucus was quantified by immunohistochemistry at 7 days post-
reinfection (i.e. 42 days of age) from uninfected RAGE-deficient mice (non-asthmatic) and infected RAGE-deficient mice (asthmatic). (Right) Lung
sections from non-asthmatic and asthmatic mice at 42 days of age were stained for smooth muscle actin by immunohistochemistry and the airway
smooth muscle (ASM) area was calculated relative to the basement membrane (BM) length of small airways. (B) Cytokine levels in the lung of RAGE-
deficient mice 7 days post-PVM or mock infection (i.e. 42 days of age). Statistical analysis was performed as described in Materials and methods with
*p0.05. Data are pooled from at least two independent experiments and shown as mean ± SEM.
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control mice (Figure 1B). These data indicate that this is an appropriate mouse model to study the
effects of asthma, and an impaired interferon response, on the emergence of influenza virus variants.
Mice with the features of paucigranulocytic asthma had increased IAV
severity
To the best of our knowledge the association between non-allergic asthma and influenza has not
been investigated. Accordingly, we sought to investigate the severity of IAV infection in the non-
allergic model of asthma described above. Asthmatic mice infected with IAV lost significantly more
body weight over time compared to non-asthmatic control mice (Figure 2A). This was associated
with increased IAV replication in the lungs of asthmatic mice at 6 days post-infection (d.p.i)
(Figure 2B). While there was an increase in the histopathology score of mock infected asthmatic
mice compared to non-asthmatic mice, there was no observable difference following IAV infection
(Figure 2C). Furthermore, asthmatic mice showed a significantly impaired type I interferon response,
with a downregulation of both IFN-a and interferon inducible MX1 following IAV infection
(Figure 2D).
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Figure 2. RAGE-deficient asthmatic mice experience more severe influenza than non-asthmatic mice. RAGE-deficient non-asthmatic and asthmatic mice
were infected with 100 (PFU) of H1N1/Auck/09. Mock control groups received PBS only. (A) Percentage weight loss of influenza A virus (IAV) or mock
infected mice. Weights are displayed as percentage of a mouse’s weight at the time of infection. Each data point represents mean ± SEM, with at least
17 mice per group. (B) Viral titres present in lung homogenate at 4 and 6 days post-infection (d.p.i.) in IAV and mock-infected mice. (C) Histopathology
score of lung sections for vascular changes, bronchitis, interstitial inflammation, alveolar inflammation, pneumocyte hypertrophy, and pleuritis
combined. (D) Cytokines in lung homogenate at 4 and 6 d.p.i. Data are normalised to Gapdh expression and fold change was calculated using the
DDCt method, expressed relative to mock infected mice. Statistical analysis was performed as described in Materials and methods with *p0.05,
comparing non-asthmatic IAV to asthmatic IAV. Data are pooled from at least two independent experiments and shown as mean ± SEM (A–D), with a
data point representing one mouse (B–D).
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An asthmatic host environment led to increased non-synonymous IAV
mutations
Having established that the asthma phenotype employed herein was associated with increased IAV
severity we next sought to determine if asthmatic mice had an increased number of IAV variants. To
do so, we used deep sequencing to analyse viral sequences isolated from the lungs of infected mice
at 4 and 6 d.p.i. Mutations were only included in the analysis if they constituted >1% of the total viral
population and were detected in a minimum of 1000 reads following quality control. Shannon’s
entropy was determined for each of the eight influenza genome segments in both 4 and 6 d.p.i.
samples (Figure 3). To account for any bias from difference in sequencing coverage, the read count
for each segment was analysed. No significant difference was observed in sequence coverage for
any of the influenza virus genes between the two treatment groups (Figure 3—figure supplement
1). Asthmatic host-derived samples showed significantly more within-host viral diversity of the PB1
segment at 6 d.p.i. (Figure 3B). To determine if the mutations were associated with a specific sec-
tion of the PB1 gene, their frequency was visualised against the nucleotide position, where no dis-
cernible trend was observed (Figure 4).
To determine if any of the mutations detected in the asthmatic mice could have contributed to
the increased IAV severity observed, we focused on unique (occurring specific to either non-asth-
matic or asthmatic hosts) non-synonymous mutations within the PB1 segment, as these were the
most likely to be of functional significance. This produced a list of 404 unique mutations across all
groups (Supplementary file 2). We then refined our analysis to only include non-synonymous muta-
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Figure 3. Asthmatic hosts produced more diverse viral variants in PB1. Influenza viral RNA isolated from the lung tissue of asthmatic (n = 27) and non-
asthmatic (n = 25) mice was analysed for viral variants at 4 and 6 days post-infection (d.p.i). (A–H) Measurement of alpha diversity presented as Shannon
entropy of viral mutations at a frequency above 1% by genome segment at the nucleotide level. Statistical analysis was performed as described in
Materials and methods with *p0.05. Data are shown as mean ± SEM.
The online version of this article includes the following figure supplement(s) for figure 3:
Figure supplement 1. Read depth of the eight Influenza genome segments from Ager-/- mice.
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detected in asthmatic compared to non-asthmatic host samples, with 32 and 5, respectively
(Table 1). Interestingly, the bulk of the mutations were focused around the priming loop, thumb,
and C-terminal extension of PB1.
We next sought to determine if any of these IAV mutations detected in mouse samples had also
been reported in pH1N1 IAV patients with asthma. To do so, post-2009 H1N1 viral sequences from
patients that listed ‘asthma’ as a medical co-morbidity (n = 51) were obtained from the Influenza
Research Database (IRD). This was compared to viral sequences obtained from 51 age and sex-
matched pH1N1 patients on the IRD with no medical co-morbidities. Strikingly, of the unique mouse
single nucleotide variants, two that were unique to asthmatic mouse samples were also detected in
clinical samples at a higher frequency in asthmatic patient samples (Table 1). Interestingly, of the
mutations identified in the clinical consensus sequence samples, the K691R mutation reached a high
enough frequency in two asthmatic mouse samples to alter the consensus sequence.
Asthmatic host-derived samples showed increased replication kinetics
in vitro
Having established that an asthmatic host generated more viral variants, specifically within PB1, we
next sought to assess if these mutations influenced the replicative ability of asthmatic and non-asth-
matic mouse-derived IAV samples in vitro. To do so, we infected Madin–Darby canine kidney
(MDCK) cells, human alveolar basal epithelial cells (A549 cells), and Immortalized Mouse Mammary
Epithelial Cells
(iMMEC) at a multiplicity of infection (MOI) of 0.01 with either lung homogenates derived from three




















Figure 4. Asthmatic hosts produced more single nucleotide variants (SNVs) in the PB1 genome segment. Influenza
viral RNA isolated from the lung tissue of asthmatic (n = 27) and non-asthmatic (n = 25) mice was analysed for viral
variants. Each data point represents the number of viral variants detected at that nucleotide position within the
viral genome PB1 segment. bp: base pair.
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Table 1. Frequency of exclusive non-synonymous viral mutations detected in PB1 at 4 and 6 days post-influenza A virus (IAV)
inoculation and their frequency in clinical samples.
Non-asthmatic Asthmatic Clinical samples (n = 51 per group)
Day 4 (n* = 13) Day 6 (n = 12) Day 4 (n = 13) Day 6 (n = 14) Non-asthmatic Asthmatic p-Value‡
M1I 50%† 0% 0%
M1L 17% 0% 0%
D2H 14% 0% 0%
N77I 14% 0% 0%
P74A 14% 0% 0%
E75D 29% 0% 0%
E75V 14% 0% 0%
D76A 14% 0% 0%
D76H 14% 0% 0%
N77V 14% 0% 0%
E78G 14% 0% 0%
S80H 14% 0% 0%
I205M 14% 0% 0%
I248V 14% 0% 0%
M616I 14% 0% 0%
R621P 14% 0% 0%
C625S 14% 0% 0%
A652P 14% 0% 0%
S654N 14% 4% 18% 0.0514
Y657H 14% 0% 0%
N671H 17% R670S 14% 0% 0%
R672P 15% 0% 0%
S673A 17% 0% 0%
I682F 15% 0% 0%
D685E 15% 0% 0%
D685H 14% 0% 0%
M688I 14% 0% 0%
Y689D 21% 0% 0%
Y689R 14% 0% 0%
Q690S 15% 0% 0%
K691R 15% 4% 16% 0.092
C692S 14% 0% 0%
C693N 14% 0% 0%
N694R 14% 0% 0%
L695I 15% 0% 0%
R727T 14% 0% 0%
*n = Total number of mouse samples.
†Percentage of mice with identified mutation.
‡Statistical comparisons were made using a two-sided fisher’s exact test.
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asthmatic mice or three non-asthmatic mice. The viruses in the asthmatic lung homogenates repli-
cated to significantly higher titres than those from non-asthmatic lung homogenates at 24 hr post-
infection in MDCK cells (Figure 5A). A similar trend was observed in mouse and human epithelial
cells (Figure 5B and C) but with a delayed rate of replication.
Interestingly, comparing two of the viral samples pre and post in vitro replication in MDCKs we
did not detect a change in the consensus sequence of the daughter population after in vitro replica-
tion compared to the consensus sequence of the parent. In terms of minority viral populations, in
one daughter population no viral variants (with non-synonymous mutations) were detected that
Asthmatic
Non-Asthmatic

























































Figure 5. Increased replication of influenza A virus (IAV) was observed in samples derived from asthmatic hosts in vitro. IAV isolated from asthmatic
hosts replicates more quickly than non-asthmatic hosts in (A) Madin–Darby canine kidney (MDCK) cells, (B) Immortalized Mouse Mammary Epithelial
Cells (iMMEC), and (C) adenocarcinomic human alveolar basal epithelial cells (A549 cells). Each cell type was infected with the indicated viruses at a
multiplicity of infection (MOI) of 0.01 (n = 3 wells/virus/time point). Mock infected data not shown. Data were analysed using a one-way ANOVA with
Holm–Sidak’s multiple comparisons test and are represented as mean ± SEM. *p<0.05. Dashed line indicates the detection limit of the assay.
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constituted between 5 and 49% of the viral population. In the second daughter population, one
non-synonymous mutation (PB1 I205M) was detected that constituted 28% of the viral population.
However, this mutation was present in the consensus sequence of the parent isolate, albeit at a
higher percentage (95%). Together, these data suggest that the increased replication of viral isolates
from asthmatic mice was not associated with a large number of additional in vitro adaptations.
PB1 C693Y and P651Q may increase the stability of the influenza RNA
polymerase protein dimer
We next sought to elucidate if any of the observed mutations identified in the asthmatic group could
be responsible for increased viral replication. To do so, four mutations were selected for structural
modelling; two that appeared in multiple mouse samples as well as clinical samples (S694N and
K691R), and two that were found in areas likely to affect function (C693Y and P651Q)
(Supplementary file 2).
None of the mutations were predicted to have a major destabilising effect and all mutations
maintained the secondary structures within PB1. The Foldx results predicted S654N (DDG  0.07
kcal/mol) and K691R (DDG 0.43 kcal/mol) to be neutral and C693Y (DDG  1.86 kcal/mol) and P651Q
(DDG  1.78 kcal/mol) to be stabilising as defined by Studer et al., 2014. As the C-terminus exten-
sion interacts with PB2, Foldx was used to highlight potential interactions between the C-terminal
mutated residues and residues of PB2. The structural modelling of C693Y identified a side chain–
side chain interaction in the mutant between PB1 C693Y and PB2 K32 in the third a-helix
(Figure 6A). In contrast, PB1 WT C693 was only predicted to interact with resides within the first
PB1 a-helix. Together, these data suggest that the C693Y mutation identified exclusively in asth-
matic hosts could alter the interaction between PB1 and PB2 within the polymerase heterotrimer.
No close contacts were identified between K691R and residues of PB2 (Figure 6A). S654N and
P651Q reside within the conserved anti-parallel b-hairpin with P651Q sitting in the tip of the b-hair-
pin (Figure 6B). Both mutations within the b-hairpin changed the orientation of the residue, which















Figure 6. Crystal structures of the mutations within PB1. (A) Mutations C693Y and K691R. The molecule is
displayed in surface view with cartoon representation of the protein backbone (PB1 magenta and PB2 sky blue).
The a-helices are labelled and PB1 C693Y and K691R and PB2 K32 are shown as sticks in the respective colours of
the subunits with the wild-type (WT) residues in pale yellow. (B) Mutations P651Q and S654N within the conserved
b-hairpin (cartoon representation in pale green). The sites of mutations are shown as sticks with the WT residues in
pale yellow.
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PB1 C693Y and P651Q increase viral polymerase activity
We next sought to investigate the individual effect of the PB1 C693Y and P651Q mutations on viral
polymerase activity using a minigenome assay, given their predicted increase in stability. Both the
PB1 C693Y and P651Q mutations within the PB1 gene increased polymerase activity when com-
pared to the WT virus polymerase (Figure 7). Together these data suggest that the C693Y and
P651Q mutations identified exclusively in asthmatic hosts may alter the interaction between PB1 and
PB2 in a stabilising manner, resulting in increased polymerase activity.
Asthmatic host-derived IAV exhibits greater disease severity and viral
diversity upon infection of a WT host
Vulnerable patient groups may be a source for the emergence of new viral strains (Honce et al.,
2020). As such, we next sought to determine if asthmatic host-derived IAV would induce greater dis-
ease severity in WT mice. We inoculated WT mice with either asthmatic or non-asthmatic host-
derived IAV and monitored them for 4 days, at which point they were euthanised. Mice infected with
asthmatic host-derived IAV had significantly more weight loss (Figure 8A), lower blood oxygen satu-
ration (Figure 8B), and higher viral titres (Figure 8C) compared to mice infected with non-asthmatic
host-derived IAV. There was also a non-significant trend towards increased viral mRNA present
(Figure 8D). Mice infected with asthmatic host-derived IAV had a significant upregulation in various
anti-viral and pro-inflammatory cytokines (Figure 8E).
Furthermore, upon infection of a non-asthmatic host with non-asthmatic-derived IAV, there is an
observable divergence in the PB1 haplotype differences as the virus continues to adapt to its host
(Figure 9A). By contrast, upon infection of a non-asthmatic host with asthmatic-derived IAV, there is
a consolidation of the PB1 mutations that arose during the initial infection (Figure 9B). Together
these data suggests that asthmatic hosts could facilitate the emergence of new strains that have
increased pathogenicity.
Discussion
Asthma was identified as the most prevalent
underlying host condition associated with hospi-
talisation for pH1N1 in 2009 (Nguyen-Van-
Tam et al., 2010; Morris et al., 2012). However,
the impact of pre-existing asthma on the severity
of influenza remains unclear (O’Riordan et al.,
2010; Dawood et al., 2011; Furuya et al.,
2015; Samarasinghe et al., 2014;
Ishikawa et al., 2012). Mouse studies modelling
allergic asthma have suggested that asthma may
mediate partial protection from severe influenza
(Furuya et al., 2015; Samarasinghe et al.,
2014; Ishikawa et al., 2012; Doorley et al.,
2017). Here, using our previously established
mouse model of non-allergic paucigranulocytic
asthma (Arikkatt et al., 2017), we show that the
impaired interferon response (characteristic of
this subtype) is associated with increased influ-
enza severity. These data suggest that further
research, both clinical and pre-clinical, into the
relationship between non-allergic asthma and
influenza virus severity is warranted.
Recent data suggest that an impaired inter-
feron response correlates with an increase in the
emergence of influenza viral variants
(Engels et al., 2017; Honce et al., 2020). Engels






























Figure 7. The PB1 C694Y and P651Q mutations
showed increased polymerase activity compared to the
wild type (WT). Influenza RNA polymerase-driven
activity is increased compared to WT in HEK 293 T cells
transfected with either the C693Y or P651Q mutation in
PB1. Data are pooled from four independent
experiments (with five biological replicates per group,
per experiment). Results are presented as a fold
change relative to WT. Statistical significance was
determined as described in the Materials and methods.
Data shown as mean ± SEM. *p<0.05.
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pregnant host environment fails to activate the innate immune response, including that of type I
interferons during IAV infection (Engels et al., 2017). The failure to mount a robust immune
response was associated with an increased viral load and a higher emergence of viral variants
(Engels et al., 2017). More recently, Honce and colleagues demonstrated that the decreased type I
interferon response within an obese micro-environment corresponded to increased viral replication
and enhanced virulence compared to WT mice (Honce et al., 2020). Consistent with these findings,
we observed increased viral variants in mice with the cardinal features of paucigranulocytic asthma,
particularly within PB1. The absence of an early immune response in the asthmatic mice, that is, lack
of type I interferon expression, may allow for the emergence of viral variants that would otherwise
be suppressed in a healthy host. Further to this, non-asthmatic host-derived viruses showed host
adaption and little sign of morbidity in WT mice, while asthmatic host-derived virus resulted in
increased morbidity. This suggests that viral variants born from an asthmatic host could (transmission
permitting) lead to the emergence of more pathogenic viral strains.
The influenza A viral RNA-dependent RNA polymerase (RdRp) forms dimers of heterotrimers con-
sisting of PA, PB1, and PB2 (Fan et al., 2019), with areas of inter-subunit contact stabilising the
trimers (Pflug et al., 2014; Sugiyama et al., 2009). Intra-host viral mutations in this complex may be
deleterious, neutral, or advantageous in terms of viral pathogenesis. The b-hairpin within the PB1
thumb domain is responsible for viral replication initiation, and deletions in this region impair viral
replication and growth (Oymans and te Velthuis, 2018).
PB1 S654N (a mutation identified in asthmatic clinical samples and those from asthmatic mice)
and PB1 P651Q (a mutation identified in asthmatic mice) reside within this priming loop. Interest-
ingly, the P651 residue has previously been shown to be the primary amino acid involved in coordi-
nating terminal initiation during replication (Te Velthuis et al., 2016). Glutamine residues have been
documented to interact with nucleotide bases (Luscombe et al., 2001), and given the position of
PB1 P651Q, it is possible that it alters the interaction with the 3’ sugar-base of the vRNA or is
A) B) C)

























































































































































































































Figure 8. Mice infected with asthmatic host-derived virus experience more severe influenza than mice infected with non-asthmatic host-derived virus.
C57BL/6 mice were infected with 2000 PFU of either asthmatic or non-asthmatic host-derived influenza A virus (IAV). (A) Percentage weight loss of mice following IAV infection. Weights are displayed as
percentage of a mouse’s weight at the time of infection. Each data point represents mean ± SEM (n = 6 per group). (B) Percentage blood oxygen saturation of mice at 4 days post-infection (d.p.i.). (C)
Viral titres present in lung homogenate at 4 d.p.i. in IAV-infected mice. (D) Viral mRNA detected by qPCR from murine lung homogenate at 4 d.p.i. Dashed line indicates the detection limit. (E) Cytokines
in lung homogenate at 4 d.p.i. Data are normalised to Gapdh expression and fold change was calculated using the DDCt method, expressed relative to samples infected with non-asthmatic-derived virus.
Statistical analysis was performed as described in Materials and methods with *p0.05. Data are shown as mean ± SEM.
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Figure 9. Asthmatic host-derived virus shows consolidation of PB1 viral variants population across parent and daughter. C57BL/6 mice were infected
with 6 days post-infection (d.p.i.) murine lung homogenate from either non-asthmatic or asthmatic hosts. Multiple dimension scaling (MDS) analysis of
the PB1 gene in (A) non-asthmatic-derived virus and (B) asthmatic-derived virus (each data point represents an individual haplotype). Data is
Figure 9 continued on next page
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beneficial to structural conformation during the initiation process. Our structural analysis of PB1
P651Q predicted a stabilising effect, which was consistent with an increase in polymerase activity rel-
ative to the WT. C693Y and K691R (both of which were identified in asthmatic mice) reside in the
first a-helix of the C-terminus, which constitutes the major binding region with the N-terminus of
PB2 and has an overall major stabilising effect on the heterotrimer (Pflug et al., 2014;
Sugiyama et al., 2009; Te Velthuis and Fodor, 2016; Sugiyama et al., 2009; Poole et al., 2007).
Deletion of any of the three a-helices within the C-terminus abolishes viral gene expression
(Poole et al., 2007). Double and single mutations in the C-terminus of PB1 alter viral RNA yield
(Sugiyama et al., 2009). Our structural analysis of PB1 C693Y predicted side chain interactions
between the mutated residue and PB2 K32 which may increase the stability of the inter-subunits
and, in turn, affect polymerase activity. Thus cumulatively, the data presented here suggest that the
PB1 C693Y and P651Q mutations detected in asthmatic mice resulted in increased viral replication
in various epithelial cell lines, and increased polymerase activity. It is well established that single
nucleotide variants (SNVs) can drastically change the replication fidelity and pathogenicity of a virus
(Lin et al., 2019; Pauly et al., 2017). As such, future research would benefit from more in-depth
analysis of the effect of C693Y or P651Q within PB1 on the fidelity of the RdRp. Nevertheless, our
results should be taken as proof of principal that an asthmatic host may be more likely to produce
more virulent viral variants – a finding that holds wide consequences for the emergence of new viral
strains.
It is important to recognise that there are several limitations associated with this study. Firstly,
paucigranulocytic asthma remains a poorly understood and poorly characterised phenotype of
asthma (Tliba and Panettieri, 2019). Accordingly, we are not aware of any other mouse model of
paucigranulocytic asthma that could be used to validate these results. Similarly, there was insufficient
information associated with the clinical sequences used herein to determine which asthma pheno-
types each patient had. Indeed, we cannot eliminate the possibility that all patients suffered from
allergic, rather than non-allergic, asthma. The clinical sequences analysed in the present study were
also obtained as consensus sequences, and do not account for minority viral variant populations
present in any individual. Additionally, only a single measure of genetic diversity was used (Shannon
entropy) (Honce et al., 2020; Abd Raman et al., 2020) although the possibility of read depth bias
was considered. Finally, it must be emphasised that these data cannot be extrapolated to other sub-
types of asthma where the relationship with influenza virus, and intra-host viral variation, may be
markedly different.
Nevertheless, despite these limitations these data suggest that in a mouse model of paucigranu-
locytic asthma there is an increased diversity of influenza viral variants some of which are associated
with increased polymerase activity. Additionally, we have demonstrated that virus derived from an
asthmatic host can cause more severe disease when introduced to a non-asthmatic host. Given these
findings, additional studies monitoring individuals with asthma (and in particular those with non-aller-
gic asthma) for increased influenza severity and the emergence of influenza virus variants may be of
value.
Materials and methods
Viral strains and titrations
PVM strain J3666 stocks were prepared from mouse lung homogenate as described previously
(Garvey et al., 2005). A/Auckland/4/2009 (Auckland/09; H1N1) stocks were prepared in embryo-
nated chicken eggs as previously described (Brauer and Chen, 2015). Viral titres were determined
by plaque assays on Madin–Darby canine kidney (MDCK) cells, as previously described (Short et al.,
2011).
Figure 9 continued
representative of six samples per group. Parent: virus derived from either asthmatic or non-asthmatic Ager-/- host. Daughter: virus isolated from C57BL/
6 mice lung following infection with host-derived virus.
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Mouse strains
RAGE-deficient mice (Ager-/-) were kindly provided by Prof. Ann-Marie Schmidt, (New York Univer-
sity Langone Medical Centre, NY, USA). Ager-/- and C57BL/6 mice were housed in individually venti-
lated cages, under alternating 12 hr light/dark periods with access to clean drinking water and food
ad libitum. All animal experiments were approved by the University of Queensland Animal Ethics
Committee (permit no. 071/17).
Establishing paucigranulocytic asthma
To model asthma development, we employed our previously described mouse model of paucigranu-
locytic asthma (Arikkatt et al., 2017). Specifically, 7-day old female and male Ager-/- mice were
infected intranasally with 10 plaque forming units (PFU) of PVM in a volume of 10 mL. Thirty-five days
after the primary infection, mice were reinfected intranasally with 100 PFU of PVM in a total volume
of 50 mL. This model reflects the fact that asthma development is often a combination of a genetic
deficiency and multiple respiratory tract infections (Arikkatt et al., 2017). ‘Non-asthmatic’ control
mice were deficient in RAGE but were mock infected with 10 mL of PBS at 7 days of age.
In vivo IAV infection
At 48 days of age, all Ager-/- mice were infected with 100 PFU of Auckland/09(H1N1) intranasally in
50 mL phosphate buffered saline (PBS) or mock-infected with PBS. Six-week-old female C57BL/6
mice were infected intranasally with 2000 PFU of either asthmatic host-derived IAV or non-asthmatic
host-derived IAV. All infections were performed intranasally under isoflurane-induced anaesthesia
using Stinger Research Aesthetic Gas Machine (Darvall, AZ, USA). Mice were monitored daily for
weight loss and clinical signs of disease. At the relevant time points, mice were euthanised with
intraperitoneal injection of a lethal dose of phentobarbitol (270 mg/kg) (Virbac, NSW, Australia).
Blood oxygen saturation
Blood oxygen saturation of C57BL/6 mice was measured at 4 d.p.i. using a collar sensor and
Mouseox Plus pulse oximeter (Starr, PA, USA).
Histology and immunohistochemistry
The left lung lobe was fixed in 10% neutral buffered formalin, routine processed and embedded in
paraffin, sectioned at 5 mm, and subsequently used for histology and immunohistochemistry. To
identify mucus producing cells, sections were stained with Periodic Acid-Schiff (PAS) and then coun-
terstained with Harris’ hematoxylin and mounted in DEPEX. Mucus production was scored based on
the percentage of mucus secreting airway epithelial cells (AECs) relative to the total number of
AECs. A minimum of five airways per sample were quantified. For immunohistochemistry, sections
were pre-treated with 10% normal goat serum for 30 min. Sections were then probed with anti-a-
SM actin (Sigma-Aldrich, MO, USA) overnight at 4˚C. Following incubation with secondary antibody,
immunoreactivity was developed with Fast Red (Sigma-Aldrich) and counterstained with Mayer’s
haematoxylin. Airway smooth muscle (ASM) was quantified essentially as described previously
(Loh et al., 2020). ASM was calculated as area per mm of basement membrane of small airways
(defined as circumference <800 mm). Lungs were assessed for vascular changes, bronchitis, intersti-
tial inflammation, alveolar inflammation, pneumocyte hypertrophy, and pleuritis (represented by a
total score) by a veterinary pathologist who was blind to the study design. All stained slides were
scanned using a digital slide scanner (Scanscope XT, Aperio Technologies, CA, USA) at 200
magnification.
Cytokine levels
Cytokine concentrations were assessed using LegendPlex mouse anti-viral panel (Biolegend, CA,
USA) according to the manufacturer’s instructions.
Quantification of influenza virus titres
Mouse lung tissues were collected in Dulbecco’s minimum essential medium (DMEM; Gibco, NY,
USA) and homogenised using a Qiagen Tissuelyser II (Qiagen, Hilden, Germany). The homogenate
was centrifuged, and the supernatant was collected and stored at  80˚C. Cell culture supernatant
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was collected at indicated time points and stored at  80˚C. Viral titres were measured by plaque
assay on MDCK cells, as described previously (Short et al., 2011).
RNA extraction, cDNA synthesis, and polymerase chain reaction (PCR)
Viral and host RNA was extracted from mouse lung samples, cDNA was synthesised, and real-time
PCR was performed as described previously (Hulme et al., 2020). Forward and reverse primers used
in the present study are supplied in Supplementary file 1. Gene expression was normalised relative
to glyceraldehyde 3-phosphate dehydrogenase (Gapdh) expression and fold change was calculated
using the DDCt method (Schmittgen and Livak, 2008). Viral copy number was determined using IAV
strain A/Puerto Rico/8/1934 H1N1 (PR8) virus matrix (M) gene cloned into pHW2000 plasmid and
viral copy number was determined as described previously (Short et al., 2013).
Viral RNA for sequencing was extracted from mouse lung, and in vitro culture supernatant sam-
ples using the High Pure Viral RNA Kit (Roche, Basel, Switzerland) according to the manufacturer’s
protocol and eluted in UltraPure DNase/RNase-Free Distilled Water (ThermoFisher Scientific, MA,
USA). Viral cDNA was synthesised using the Transcriptor First Strand cDNA Synthesis Kit (Roche)
essentially as described previously (Mancera Gracia et al., 2017). Briefly, two reactions were per-
formed per sample, using either 2.5 mM CommonUni12A primer (GCCGGAGCTCTGCAGATATCAG-
CAAAAGCAGG) or 2.5 mM CommonUni12G primer (GCCGGAGCTCTGCAGATA
TCAGCGAAAGCAGG). Both reactions were incubated for 10 min at 65˚C and cooled immediately
on ice. RNA was reverse transcribed using Mastercycler Pro 6325 (Eppendorf, Hamburg, Germany).
cDNA was pooled at a 1:1 ratio and amplified using the Phusion High-Fidelity DNA Polymerase kit
(New England Biolabs, MA, USA) with 10 mM CommonUni13 primer (GCCGGAGCTCTGCAGATA
TCAGTAGAAACAAGG). cDNA was amplified using Mastercycler Pro 6325 (Eppendorf). MinElute
PCR Purification Kit (Qiagen) was used to purify the PCR products. To elute, unheated UltraPure
DNase/RNase-Free distilled water was used instead of elution buffer. The presence of the correct
size PCR products was confirmed using a 1% agarose gel containing SYBR Safe DNA Gel Stain (Ther-
moFisher Scientific) at 100 Volt and visualised by the Amersham Imager 600 (GE Healthcare, IL,
USA).
Next generation sequencing (NGS) for viral genes
Libraries were prepared from viral cDNA amplicons using Nextera XT DNA library prep kit (Illumina,
cat no. FC-131–1024) and were deep sequenced (0.5 Gb) on an Illumina Nextseq 2000 Platform at
the Australian Centre of Ecogenomics (the University of Queensland, QLD, Australia).
NGS analysis and Shannon entropy
The haplotypes for each sample were reconstructed for each gene segment using a previously pub-
lished pipeline (Cacciabue et al., 2020). In brief, FastQC (Andrews, 2010) was used for quality
assurance of the NGS paired-end raw reads followed by BBtools (Bushnell, 2014), for removing and
filtering adapters and low-quality reads. Bowtie2 (Langmead and Salzberg, 2012), an aligner tool to
align the trimmed reads to the selected reference of the influenza strain (i.e. the inoculum), was then
used. Samtools suite (Li et al., 2009) was used to sort, index, and generate depth and coverage sta-
tistics for read alignment files. Next, CliqueSNV (Knyazev, 2020) was used to infer the haplotypes
and frequencies for all eight gene segments for each sample.
Shannon entropy (abundance-based diversity) was calculated using QSutils, an R package (Guer-
rero-Murillo and Font, 2020). During analysis the following assumptions were made: each paired-
end read present in an alignment comes from a true viral haplotype from the original population,
the occurrence of variants in a given gene segment is independent of the rest of the genes, and
each haplotype in the actual population has an equal chance to be sampled.
Multiple dimension scaling (MDS) (LMDS V1.0 – R package) was utilised to visualise distance
matrices to understand the dynamics of haplotype distance in a given quasi species population
across donor and acceptor hosts (i.e. C57BL/6 mice infected with either 6 d.p.i. murine lung homog-
enate from asthmatic or non-asthmatic host) (Jombart, 2016). We used IRMA (iterative refinement
meta-genome assembler) (Shepard et al., 2016) for variant calling and each of the variant in the
coding sequence of PB1 gene was translated to the corresponding amino acid residue compared to
the reference.
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All scripts generated for this study can be found at https://github.com/akaraw/Hulme_et_
al (Karawita, 2021) and the workflow for haplotype reconstruction can be found in
Supplementary file 3.
Within-host alpha diversity was measured using Shannon’s entropy (H):
H xð Þ ¼
Xn
i
P ið Þ lnP ið Þ
Identification of asthma associated mutations of IAV in clinical samples
H1N1 PB1sequences were obtained from the NIAID IRD through the website at http://www.fludb.
org. The following settings were used for selecting human surveillance data following the 2009 pan-
demic: date range 2009, subtype H1N1, all countries, all sexes, and age ranges; exclude laboratory
strains and duplicate sequences. Only records containing clinical metadata were returned. Using
these criteria, a total of 51 human clinical samples with asthma as a medical condition were
observed. Fifty-one age and sex matched human clinical samples with no medical conditions were
taken for comparison. Samples were aligned using MEGA-X (version 10.1) (Pennsylvania State Uni-
versity, PA, USA) and the presence or absence of the mutations identified in vivo was determined
using amino acid position.
IAV mutagenesis
The PB1-C693Y and PB1-P651Q mutations were independently introduced into the PB1 gene seg-
ment of influenza A/Auckland/2009 (H1N1) using the Q5 Site-Directed Mutagenesis Kit (New Eng-
land BioLabs) as per the manufacturer’s instructions. Mutations were confirmed using the PureYield
Plasmid Miniprep System Kit (Promega, WI, USA) as per the manufacturer’s instructions and
sequenced at the AEGRC Genotyping and Sequencing Facility at the University of Queensland. DNA
was isolated using an EndoFree Plasmid Maxi Kit (Qiagen) as per the manufacturer’s instructions.
Cell culture
Human embryonic kidney 293 with large T antigen (HEK 293T) cells, MDCK cells, adenocarcinomic
human alveolar basal epithelial cells (A549 cells), and Immortalized Mouse Mammary Epithelial Cells
(iMMEC) were cultured in DMEM (Gibco) containing 10% foetal bovine serum (FBS; Sigma-Aldrich)
and 1% penicillin streptomycin (Lonza, Basel, Switzerland) in a humidified atmosphere of 5% CO2 at
37˚C. All cell lines were obtained from American Type Culture Collection (ATCC; Virginia, USA) and
have no mycoplasma contamination to report.
In vitro viral replication kinetics
Multicycle viral replication kinetics were determined by inoculating a confluent monolayer of cells
with the lung homogenate of infected mice at a multiplicity of infection (MOI) of 0.01 for 1 hr. Cells
were then washed with PBS three times and fresh medium (DMEM; Gibco) was added containing
TPCK-trypsin (Thermofisher Scientific). At 0, 6, 24, 48, and 72 hr post inoculation, cell culture super-
natant was collected and used to determine virus titres, as described above.
Influenza virus polymerase assay
Reporter plasmids, Fluc (0.25 mg) and pRL (0.01 mg) were co-transfected with expression plasmids
encoding the AUCK/09 PA, PB1, PB2, PA, and NP (0.25 mg per plasmid) into HEK 293 T cells seeded
on a 24-well plate using the calcium phosphate mediated method (Kwon and Firestein, 2013).
Luciferase assays were performed using a dual-specific luciferase assay kit (Promega). A Renilla lucif-
erase reporter vector was used as the internal control. Firefly luciferase activity was normalised to
Renilla luciferase activity for each well. Luminescence was measured on a CLARIOstar Plus micro-
plate reader (BMG Labtech, Ortenberg, Germany) in flat 96-white well plates (Corning, Amsterdam,
the Netherlands).
Modelling of the mutations
For K691R and C693Y the crystal structure of the PB1–PB2 subunits from IAV (A/Puerto Rico/8/1934
(H1N1)) was used as a model (PDB: 3A1G) (Sugiyama et al., 2009). For P651Q and S654N the struc-
ture of the influenza A bat polymerase complex (PDB: 4WSB) was used as a model (Pflug et al.,
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2014). The effects of conformational stability were estimated using FoldX (version 5)
(Schymkowitz et al., 2005) and each mutation was engineered separately. For the FoldX analysis
the subroutines RepairPDB, BuildModel, and PrintNetworks were used. Images were created with
PyMOL (The PyMOL Molecular Graphics System, Version 2.4.0 Schrödinger, LLC).
Statistical analysis
Statistical analyses were performed using Graph Pad Prism software (version 9.0.1) for Windows
(GraphPad Software, CA, USA). Data were tested for normality using the Shapiro–Wilk test. Where
data was normally distributed, data was analysed using a two-way ANOVA (with Tukey’s multiple
comparison test), a one-way ANOVA (with Tukey’s multiple comparison test), an unpaired Student’s
t-test, or a one sample t test as appropriate. Where data was not normally distributed, data was ana-
lysed using a Kruskal–Wallis test (with Dunn’s multiple comparisons test), a Mann–Whitney U-test or
a Wilcoxon signed-rank test as appropriate. Clinical samples were analysed using a two-sided fisher’s
exact test.
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